Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Safety, Pharmacology, and Regulatory Science : Studying how AOD 9604 is absorbed, distributed, metabolized, and excreted in the body, as well as comparing its safety profile with that of full-length growth hormone
The LEADER and SUSTAIN-6 trials, which followed diabetic patients for 37 years on GLP-1 therapy, documented reduced heart attacks and strokes without accumulation of serious toxicity
159.21 g/mol (free cation portion) CAS: 90692-39-0 Disclaimer This product is intended for laboratory research use only
The most relevant research areas include muscle metabolism, bone metabolism, glucose homeostasis, tissue regeneration, glucocorticoid response, cardiovascular function, neuroendocrine tissues, and experimental models evaluating the relationship between GH, IGF-1, ghrelin, and energy regulation
US$ 21.63
US$ 24.94
US$ 29.55
US$ 26.29
US$ 22.53
